
Glenmark Pharma shares increase 10%, hit upper circuit limit
Glenmark Pharma Share Price: Shares of Glenmark Pharmaceuticals Ltd surged 10 per cent on Friday after the company announced that it has signed an up to USD 2 billion deal with AbbVie to commercialise its under-development drug for treating cancer and autoimmune diseases, in one of the biggest transactions in the pharma sector. The stock…